NEW ORLEANS, LA—A risk model based on data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) ...
Aortic stenosis (AS) is a progressive heart valve disease that leads to the narrowing of the aortic valve opening, restricting blood flow from the heart to the rest of the body.
Transcatheter Aortic Valve Implantation (TAVI) gives broadly comparable results to conventional open surgery, with equal efficacy, faster recovery time and improved quality of life at one year, ...
Annual Meeting, investigators presented a late-breaking study focused on surgical aortic valve replacement (SAVR) following ...
PARIS — Despite some potential advantages, transcatheter aortic valve implantation (TAVI) failed to meet the primary prespecified threshold for noninferiority to surgical aortic valve replacement in ...
TCTMD reported in-depth on the Transcatheter Valves and Vessels (TCW) trial, May 14, 2024, at the EuroPCR 2024 meeting. The full manuscript was subsequently published in The Lancet on December 4, 2024 ...
Objective Multidisciplinary team (MDT) meetings are central to treatment decisions in aortic stenosis (AS), particularly for borderline or high-risk patients. This study evaluates long-term, ...
Abbott Laboratories, Inc. ABT recently announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results